Hillman Solutions (HLMN) 10-K/A3 May 212020 FY Annual report (amended)Financial data

Company Profile

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2020	Mar. 01, 2021
Document and Entity Information
Document Type	10-K/A
Document Period End Date	Dec. 31, 2020
Entity Registrant Name	Landcadia Holdings III, Inc.
Entity Central Index Key	0001822492
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Public Float	$ 0
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	true
Amendment Description	Amendment No. 1
Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
Document and Entity Information
Security Exchange Name	NASDAQ
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
Trading Symbol	LCYAU
Class A common stock
Document and Entity Information
Security Exchange Name	NASDAQ
Title of 12(b) Security	Class A common stock, $0.0001 par value
Trading Symbol	LCY
Entity Common Stock, Shares Outstanding		50,000,000
Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
Document and Entity Information
Security Exchange Name	NASDAQ
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol	LCYAW
Class B common stock
Document and Entity Information
Entity Common Stock, Shares Outstanding		12,500,000

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 1,017,406	$ 0
Prepaid expenses	105,838	0
Total current assets	1,123,244	0
Cash and marketable securities held in trust	500,078,624	0
Deferred tax asset	0	0
Total assets	501,201,868	0
Current liabilities:
Accounts payable and accrued liabilities	127,450	0
Total current liabilities	127,450	0
Deferred underwriting commissions	17,500,000	0
Warrant derivative liability	55,720,000	0
Total liabilities	73,347,450	0
Commitments and contingencies
Class A common stock subject to possible redemption, 42,278,793 shares at redemption value of $10.00	422,854,408	0
Stockholder's Equity:
Preferred stock, $0.0001 par value, 1,000,000 authorized, no shares issued or outstanding	0	0
Additional paid-in capital	33,888,383	306
Accumulated deficit	(28,890,395)	0
Subscription notes receivable, affiliates	0	(1,000)
Total stockholder's equity	5,000,010	0
Total liabilities and stockholder's equity	501,201,868	0
Class A common stock
Stockholder's Equity:
Common stock	772	0
Class B common stock
Stockholder's Equity:
Common stock	$ 1,250	$ 694

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical)	Dec. 31, 2020$ / sharesshares
Shares subject to possible redemption	42,278,793
Preferred stock par value (in dollars per share) \| $ / shares	$ 0.0001
Preferred stock authorized	1,000,000
Preferred stock issued	0
Preferred stock outstanding	0
Class A common stock
Shares subject to possible redemption	42,278,793
Shares subject to possible redemption, redemption value per share \| $ / shares	$ 10
Common stock par value (in dollars per share) \| $ / shares	$ 0.0001
Common stock authorized	380,000,000
Common stock issued	7,721,207
Common stock outstanding	7,721,207
Class B common stock
Common stock par value (in dollars per share) \| $ / shares	$ 0.0001
Common stock authorized	20,000,000
Common stock issued	12,500,000

Statements of Operations

Statements of Operations - USD ($)	10 Months Ended	12 Months Ended
Statements of Operations - USD ($)	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Expenses:
General and administrative expenses	$ 0	$ 1,279,019	$ 0
Loss from operations	0	(1,279,019)	0
Other income (expense):
Interest income	0	78,624	0
Change in fair value of warrant derivative liability	0	(27,690,000)	0
Total other income (expense)	0	(27,611,376)	0
Loss before taxes	0	(28,890,395)	0
Tax benefit (provision)	0	0	0
Net Loss	$ 0	$ (28,890,395)	$ 0
Basic and diluted loss per share:
Net loss per share available to common shares	$ 0	$ (2.99)	$ 0
Basic and diluted weighted average number of shares outstanding	6,037,500	9,654,569	6,037,500

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity - USD ($)	Class A common stockCommon Stock	Class B common stockCommon Stock	Additional Paid-in Capital	Accumulated deficit	Subscription note receivable, affiliates	Total
Balance at Mar. 13, 2018	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Balance (in shares) at Mar. 13, 2018	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class B shares issued	$ 0	$ 694	306	0	(1,000)	0
Class B shares issued (in shares)		6,943,125
Balance at Dec. 31, 2018	$ 0	$ 694	306	0	(1,000)	0
Balance (in shares) at Dec. 31, 2018	0	6,943,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 0	$ 0	0	0	0	0
Balance at Dec. 31, 2019	0	$ 694	306	0	(1,000)	0
Balance (in shares) at Dec. 31, 2019		6,943,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class B shares issued	0	$ 744	326	0	(1,070)	0
Class B shares issued (in shares)		7,431,875
Excess cash received over fair value of sponsor warrants	0	$ 0	2,800,000	0	0	2,800,000
Class A shares issued, less fair value of public warrants	$ 5,000	0	481,165,000	0	0	481,170,000
Class A shares issued, less fair value of public warrants (in shares)	50,000,000
Underwriters commissions and offering costs for public shares	$ 0	0	(27,227,257)	0	0	(27,227,257)
Class A shares subject to redemption	$ (4,228)	0	(422,850,180)	0	0	(422,854,408)
Class A shares subject to redemption (in shares)	(42,278,793)
Shares forfeited	$ 0	$ (188)	188	0	0	0
Shares forfeited (in shares)		(1,875,000)
Payment of affiliate note receivable	0	$ 0	0	0	2,070	2,070
Net income (loss)	0	0	0	(28,890,395)	0	(28,890,395)
Balance at Dec. 31, 2020	$ 772	$ 1,250	$ 33,888,383	$ (28,890,395)	$ 0	$ 5,000,010
Balance (in shares) at Dec. 31, 2020	7,721,207	12,500,000

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
Statements of Cash Flows - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (28,890,395)	$ 0
Adjustments to reconcile net loss to net cash used in operating activities:
Trust account interest income	(78,624)	0
Change in fair value of warrant derivative liability	27,690,000	0
Changes in operating assets and liabilities:
Decrease (increase) in prepaid expenses	(105,838)	0
Increase (decrease) in accounts payable and accrued liabilities	127,450	0
Net cash used in operating activities	(1,257,407)	0
Cash flows from investing activities:
Cash deposited in trust account	(500,000,000)	0
Net cash used in investing activities	(500,000,000)	0
Cash flows from financing activities:
Proceeds from public offering	500,000,000	0
Proceeds from sale of private placement warrants	12,000,000	0
Payment for underwriting discounts	(8,953,885)	0
Payment of offering costs	(606,622)	0
Payment of notes payable, affiliates	(166,750)	0
Proceeds from stock subscriptions receivable, affiliates	2,070	0
Net cash provided by financing activities	502,274,813	0
Net increase (decrease) in cash and cash equivalents	1,017,406	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	1,017,406	0
Supplemental schedule of non-cash financing activities:
Change in value of common shares subject to possible conversion	(26,989,759)	0
Initial classification of common shares subject to possible conversion	449,844,167	0
Deferred underwriting commissions	17,500,000	0
Initial warrant derivative liability	28,030,000	0
Offering costs included in Notes payable, affiliates	$ 166,750	$ 0

Nature of Business

Nature of Business	12 Months Ended
Nature of Business	Dec. 31, 2020
Nature of Business
Nature of Business	1. Nature of Business Business Landcadia III Holdings, Inc., (the “Company”), was formed as Automalyst LLC, a Delaware limited liability company on March 13, 2018 and converted into a Delaware corporation of August 24, 2020. We consummated an initial public offering (“Public Offering”) on October 14, 2020. The Company has not had any significant operations to date. The Company was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). On, January 24, 2021 we entered into an Agreement and Plan of Merger with HMAN Group Holdings Inc., a Delaware corporation (“Hillman”). There is no assurance that the Company’s plans to consummate a Business Combination will be successful. All activity through December 31, 2020 relates to the Company’s formation and its initial public offering of units (the “Public Offering”), which is described below. Sponsors The Company’s sponsors are TJF LLC (“TJF”) and Jefferies Financial Group Inc. (“JFG” and, together with TJF, the “Sponsors”). TJF is wholly owned by Tilman J. Fertitta, the Company’s Co-Chairman and Chief Executive Officer. Financing The Company intends to finance its Business Combination in part with proceeds from its $500,000,000 Public Offering and $12,000,000 private placement (the “Private Placement”) of private placement warrants (the “Sponsor Warrants”), see Notes 4 and 5. The registration statement for the Public Offering was declared effective by the U.S. Securities and Exchange Commission (“SEC”) on October 8, 2020. The Company consummated the Public Offering of 50,000,000 units (the “Units”), at $10.00 per Unit on October 14, 2020, generating gross proceeds of $500,000,000. Simultaneously with the closing of the Public Offering, the Company consummated the Private Placement of an aggregate of 8,000,000 Sponsor Warrants at a price of $1.50 per Sponsor Warrant, generating proceeds of $12,000,000. Upon the closing of the Public Offering and Private Placement, $500,000,000 from the net proceeds of the sale of the Units in the Public Offering and the Private Placement was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee (the “Trust Account”). The underwriters did not exercise their option to purchase additional units. Trust Account The proceeds held in the Trust Account can only be invested in permitted United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a‑7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Company’s second amended and restated certificate of incorporation (the “Charter”) provides that, other than the withdrawal of interest to pay tax obligations (less up to $100,000 interest to pay dissolution expenses), none of the funds held in the Trust Account will be released until the earliest of: (i) the completion of the Business Combination; (ii) the redemption of any shares of Class A common stock included in the Units being sold in the Public Offering (“Public Shares”) properly submitted in connection with a stockholder vote to amend the Charter to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete the Business Combination by October 14, 2022 (within 24 months from the closing of the Public Offering); or to provide for redemption in connection with a Business Combination; or (iii) the redemption of the Public Shares if the Company is unable to complete the Business Combination by October 14, 2022, subject to applicable law. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering and Private Placement, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (excluding deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the Company’s signing a definitive agreement in connection with an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Sponsors and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of the Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a stockholder vote to approve an amendment to the Charter to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination by October 14, 2022, or to provide for redemption in connection with a Business Combination and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete a Business Combination by October 14, 2022, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete a Business Combination within the prescribed time frame; and (iv) vote any Founder Shares held by them and any Public Shares purchased during or after the Public Offering (including in open market and privately-negotiated transactions) in favor of the Business Combination. The Company, after signing a definitive agreement for the Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the Business Combination, including interest earned on the Trust Account and not previously released to the Company to pay its taxes, or (ii) provide stockholders with the opportunity to sell their shares to the Company by means of a tender offer for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to commencement of the tender offer, including interest earned on the Trust Account and not previously released to the Company to pay its taxes. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval. If the Company seeks stockholder approval, it will complete the Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. However, in no event will the Company redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of the Public Shares and the related Business Combination, and instead may search for an alternate Business Combination. Notwithstanding the foregoing redemption rights, if the Company seeks stockholder approval of the Business Combination and it does not conduct redemptions in connection with the Business Combination pursuant to the tender offer rules, the Charter provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold in the Public Offering, without the Company’s prior consent. The Public Shares have been recorded at their redemption amount and classified as temporary equity (“Redeemable Shares”), in accordance with the Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 480, ‘‘Distinguishing Liabilities from Equity.’’ The amount in the Trust Account was initially $10.00 per Public Share ($500,000,000 held in the Trust Account divided by 50,000,000 Public Shares). See Note 3. The Company will have until October 14, 2022, to complete the Business Combination. If the Company does not complete the Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares for a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims to creditors and the requirements of other applicable law. The Sponsors and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with respect to any Founder Shares (as defined below) held by them if the Company fails to complete its Business Combination by October 14, 2022; however, the Sponsors, officers and directors are entitled to liquidating distributions from the Trust Account with respect to Public Shares held by them if the Company does not complete the Business Combination within the required time period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per Unit in the Public Offering. Pursuant to the letter agreement referenced above, the Sponsors, officers and directors agreed that, if the Company submits the Business Combination to the Company’s public stockholders for a vote, such parties will vote their Founder Shares and any Public Shares in favor of the Business Combination. Subsequent Events The Company has evaluated subsequent events and transactions that occurred after the balance sheet date up to the date the financial statements were issued. The Company did not identify any subsequent events that would have required adjustment to or disclosure in the financial statements, other than those included herein. Fiscal Year End The Company has a December 31 fiscal year-end.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting	12 Months Ended
	Dec. 31, 2020
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting	2. Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting The consolidated financial statements for the year ended December 31, 2020 included in the Original 10-K, filed March 12, 2021, have been restated to reflect the fair value of our warrant derivative liability, which was initially recorded as a component of equity. The Company recently evaluated the terms of its warrants and determined such warrants should be classified as a liability measured at fair value, with the changes in fair value each period reported in earnings in accordance with GAAP. Volatility in our Common Stock and Public Warrants may result in significant changes in the value of the derivatives and resulting gains and losses on our statement of operations. Further if our Sponsor Warrants are held by someone other initial purchases of the Sponsor Warrants or their permitted transferees, the Sponsor Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Because the terms of the Sponsor Warrants and Public Warrants are so similar, we classified both types of warrants as a derivative liability measured at fair value. The Company determined, at the time of the Public Offering, the initial value of its Public Warrants and Sponsor Warrants were $18,830,000 and $9,200,000, respectively. As of December 31, 2020, the value of our Public Warrants and Sponsor Warrants were $37,000,000 and $18,720,000, respectively. We have restated our December 31, 2020 financial statements to reflect the initial warrant derivative liability of $28,030,000 with an offsetting amount recorded in additional paid in capital. Subsequently we adjusted the liability to fair value at December 31, 2020 and recorded a change in fair value of warrant derivative liability of $27,690,000 in other income and expense on our statement of operations. As of December 31, 2020 our warrant derivative liability was $55,720,000. Because a portion of the Public Offering is now accounted for as a liability at fair value instead of equity, we reclassed a portion of transaction costs associated with the Public Offering. We allocated offering costs and underwriting discounts between the public equity and warrants based on the relative fair value method. On October 14, 2020, we issued $500,000,000 of Public Units. We have determined fair value of the Public Warrants on October 14, 2020 was $18,830,000, and therefore, assigned a value to the Public Warrants of $18,830,000 and to the Common Stock of $481,170,000. Because the fair value of the Public Warrants is 3.7% of total Public Units, we reclassed $1,046,115, or 3.7%, of underwriting discounts and offering costs from additional paid in capital to general and administrative expenses in the 4th quarter. As the bulk of these expenses are commissions, we have included the entire amount in underwriting discounts in the Statement of Cash Flows. The following table summarizes the effect of the restatement on each financial statement line item, as indicated: As previously reported Adjustment As restated Balance Sheet as of October 14, 2020 Warrant derivative liability $ — $ 28,030,000 $ 28,030,000 Total liabilities 19,092,923 28,030,000 47,122,923 Class A common stock subject to possible redemption 477,874,167 (28,030,000) 449,844,167 Class A commmon stock 221 281 502 Additional paid-in capital 5,002,872 1,045,834 6,048,706 Accumulated deficit (2,451) (1,046,115) (1,048,566) Balance Sheet as of December 31, 2020 Warrant derivative liability $ — $ 55,720,000 $ 55,720,000 Total liabilities 17,627,450 55,720,000 73,347,450 Class A common stock subject to possible redemption 478,574,408 (55,720,000) 422,854,408 Class A commmon stock 215 557 772 Additional paid-in capital 5,152,825 28,735,558 33,888,383 Accumulated deficit (154,280) (28,736,115) (28,890,395) Statement of Operations as of December 31, 2020 General and administrative expenses $ (232,904) $ (1,046,115) $ (1,279,019) Change in fair value of warrant derivative liability — (27,690,000) (27,690,000) Total other income (expense) 78,624 (27,690,000) (27,611,376) Net loss (154,280) (28,736,115) (28,890,395) Basic and diluted loss per share (0.02) (2.97) (2.99) Statement of Cash Flows as of December 31, 2020 Net loss $ (154,280) $ (28,736,115) $ (28,890,395) Change in fair value of warrant derivative liability — (27,690,000) (27,690,000) Net cash used in operating activities (211,292) (1,046,115) (1,257,407) Payment for underwriting discounts (10,000,000) 1,046,115 (8,953,885) Net cash provided by financing activites 501,228,698 1,046,115 502,274,813

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2020
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	3. Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements include the accounts of the Company and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Use of Estimates The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used. Cash and Cash equivalents The Company considers cash equivalents to be all short-term investments with an original maturity of three months or less when purchased. The Company did not have any cash equivalents as of December 31, 2020 and 2019. Cash consists of proceeds from the Public Offering and Private Placement held outside of the Trust Account and may be used to pay for business, legal and accounting due diligence for the Business Combination and continuing general and administrative expenses. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts with a financial institution which may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and the Company believes that it is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The Company classifies financial instruments under FASB ASC 820, “Fair Value Measurement,” for its financial assets and liabilities that are reported at fair value at each reporting period. The carrying value of the Company’s cash and cash equivalents, and accrued liabilities, approximates their fair value due to the short-term nature of such instruments. Our financial instruments that are subject to fair value measurements consist of our warrant derivative liability. Fair value is measured based on an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions market participants would use in pricing an asset or liability. Assets and liabilities measured at fair value are based on a market valuation approach using prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. As a basis for considering such assumptions, a three-tiered fair value hierarchy is established, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets that are observable, either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. See Note 9 for further information. Offering Costs Total offering costs were $775,000 and consisted of legal, accounting, other costs incurred in connection with the formation and preparation of the Public Offering. Underwriting commissions for the Public Offering were $27,500,000, of which $17,500,000 have been deferred until the completion of the Business Combination. Because the Public Warrants have been accounted for as a liability at fair value instead of equity, the Company applied the relative fair value method and allocated a portion of offering costs and underwriting commissions to expenses with the remainder charged to additional paid in capital at the closing of the Offering. Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities were $127,450 as of December 31, 2020, and primarily consist of Delaware franchise tax expenses and costs incurred for the formation and preparation of the Public Offering with corresponding amounts charged to Offering costs. Warrant Liabilities In accordance with ASC 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, entities must consider whether to classify contracts that may be settled in its own stock, such as warrants, as equity of the entity or as an asset or liability. If an event that is not within the entity’s control could require net cash settlement, then the contract should be classified as an asset or a liability rather than as equity. We have determined because the terms of Public Warrants include a provision that entitles all warrantholders to cash for their warrants in the event of a qualifying cash tender offer, while only certain of the holders of the underlying shares of common stock would be entitled to cash, our warrants should be classified as liability measured at fair value, with changes in fair value each period reported in earnings. Volatility in our Common Stock and Public Warrants may result in significant changes in the value of the derivatives and resulting gains and losses on our statement of operations. Loss Per Common Share Basic loss per common share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding during the period. All shares of Class B common stock are assumed to convert to shares of Class A common stock on a one-for-one basis. Consistent with FASB ASC 480, shares of Class A common stock subject to possible redemption, as well as their pro rata share of undistributed trust earnings consistent with the two-class method, have been excluded from the calculation of loss per common share for the years ended December 31, 2020, 2019 and the period from March 13, 2018 (inception) to December 31, 2018. Such shares, if redeemed, only participate in their pro rata share of trust earnings, see Note 3. Diluted loss per share includes the incremental number of shares of common stock to be issued in connection with the conversion of Class B common stock or to settle warrants, as calculated using the treasury stock method. For the years ended December 31, 2020, 2019 and the period from March 13, 2018 (inception) to December 31, 2018, the Company did not have any dilutive warrants, securities or other contracts that could, potentially, be exercised or converted into common stock. As a result, diluted loss per common share is the same as basic loss per common share for all periods presented. Further, in accordance with FASB ASC 260, the loss per share calculation reflects the effect of the stock splits as discussed in Note 4 for all periods presented. See Note 10 for further information. Income Taxes The Company was taxed as a limited liability company prior to August 24, 2020, therefore all tax implications were the responsibility of its member As of August 24, 2020 the Company elected to be taxes as a C Corporation. The Company complies with the accounting and reporting requirements of FASB ASC, 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. There were no unrecognized tax benefits as of December 31, 2020, 2019 and 2018. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at December 31, 2020, 2019 and 2018. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. See Note 11 for further information. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Stockholder's Equity

Stockholder's Equity	12 Months Ended
Stockholder's Equity	Dec. 31, 2020
Stockholder's Equity
Stockholder's Equity	4. Stockholders’ Equity On March 13, 2018, JFG, through a subsidiary, purchased a 100% of the membership interest in the Company for $1,000. On August 24, 2020, TJF purchased a 51.7% membership interest in the Company for $1,070. Simultaneously, the Company converted from a limited liability company to a corporation and its previously outstanding membership interest converted into shares of Class B common stock. The total number of authorized shares of all classes of capital stock is 401,000,000, of which 380,000,000 shares are Class A shares at par value $0.0001 per share; 20,000,000 shares are Class B shares at par value $0.0001 per share; and 1,000,000 shares are preferred stock at par value $0.0001 per share. The Sponsors held an aggregate of 11,500,000 Class B shares based on the proportional interest in the Company. Further, on September 16, 2020, we conducted a 1:1.25 stock split of the Founder Shares so that a total of 14,375,000 Founder Shares were issued and outstanding. An aggregate of 1,875,000 Founder Shares were forfeited because the underwriters did not exercise their over-allotment option. As of December 31, 2020 JFG and TJF owned 12,500,000 Founder Shares based on their proportional interest in the Company. The financial statements reflect the changes in stock retroactively for all periods presented. Following these transactions, the Company had $2,070 of invested capital, or approximately $0.0001 per share. Redeemable Shares All of the 50,000,000 Public Shares sold as part of the Public Offering contain a redemption feature as defined in the Public Offering. In accordance with FASB ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. The Company’s amended and restated certificate of incorporation provides a minimum net tangible asset threshold of $5,000,001. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of the security to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of Redemption Shares will be affected by charges against additional paid-in capital. At December 31, 2020 there were 50,000,000 Public Shares, of which 42,278,793 were classified as Redeemable Shares, classified outside of permanent equity, and 7,721,207 classified as Class A common stock. For further information on the Founder Shares, see Note 6.

Public Offering

Public Offering	12 Months Ended
Public Offering	Dec. 31, 2020
Public Offering
Public Offering	5. Public Offering Public Units In the Public Offering, which closed October 14, 2020, the Company sold 50,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of the Company’s Class A common stock, $0.0001 par value and one-third of one redeemable warrant (each whole warrant is a “Public Warrant”). Under the terms of the warrant agreement, the Company has agreed to use its best efforts to file a new registration statement under the Securities Act no later than 15 business days following the completion of the Business Combination covering the shares of Class A common stock issuable upon exercise of the Public Warrants, to use its best efforts to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the Public Warrants expire or are redeemed. If a registration statement covering the shares of Class A common stock issuable upon exercise of the Public Warrants is not effective by the 60 th business day after the closing of the Business Combination, warrantholders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, If the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(l) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement. Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. Each Public Warrant will become exercisable on the later of 30 days after the completion of the Business Combination or 12 months from the closing of the Public Offering. However, if the Company does not complete the Business Combination on or prior to October 14, 2022, the Warrants will expire at the end of such period. If the Company is unable to deliver registered shares of Class A common stock to the holder upon exercise of Public Warrants issued in connection with the Units during the exercise period, there will be no net cash settlement of these Public Warrants and the Public Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the warrant agreement. Once the Public Warrants become exercisable, the Company may call the warrants for redemption: (i) in whole and not in part; (ii) at a price of $0.01 per warrant; (iii) upon not less than 30 days’ prior written notice of redemption to each warrant holder; and (iv) if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 value per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. Underwriting Commissions The Company paid an underwriting discount of $10,000,000 ($0.20 per Unit sold) to the underwriters at the closing of the Public Offering on October 14, 2020, with an additional fee (“Deferred Discount”) of $17,500,000 ($0.35 per Unit sold) payable upon the Company’s completion of the Business Combination. The Deferred Discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its Business Combination. See Note 5 for further information on underwriting commissions.

Related Party Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2020
Related Party Transactions
Related Party Transactions	6. Related Party Transactions Founder Shares The Founder Shares are identical to the Public Shares except that the Founder Shares are subject to certain transfer restrictions and the holders of the Founder Shares will have the right to elect all of the Company’s directors prior to the Business Combination. The Founder Shares will automatically convert into shares of Class A common stock at the time of the Business Combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights. The Sponsors collectively own 22.4% of the Company’s issued and outstanding shares of common stock. The holders of the Founder Shares have agreed not to transfer, assign or sell any of their Founder Shares until one year after the completion of the Business Combination, or earlier if, subsequent to the Business Combination, (i) the closing price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period commencing at least 150 days after the Business Combination or (ii) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the Business Combination that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property (the ‘‘Lock Up Period’’). The Founder Shares will automatically convert into shares of Class A common stock concurrently with or immediately following the consummation of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of all shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the Business Combination and any private placement-equivalent warrants issued to the Sponsors, officers or directors upon conversion of working capital loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. Sponsor Warrants In conjunction with the Public Offering that closed on October 14, 2020 the Sponsors purchased an aggregate of 8,000,000 Sponsor Warrants at a price of $1.50 per warrant ($12,000,000 in the aggregate) in the Private Placement. A portion of the purchase price of the Sponsor Warrants was added to the proceeds from the Public Offering to be held in the Trust Account such that at closing of the Public Offering, $500,000,000 was placed in the Trust Account. Each Sponsor Warrant entitles the holder to purchase one share of Class A common stock at $11.50 per share. The Sponsor Warrants (including the Class A common stock issuable upon exercise of the Sponsor Warrants) are not transferable, assignable or salable until 30 days after the completion of the Business Combination and they are non-redeemable so long as they are held by the initial purchasers of the Sponsor Warrants or their permitted transferees. If the Sponsor Warrants are held by someone other than the initial purchasers of the Sponsor Warrants or their permitted transferees, the Sponsor Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the warrants included in the Units being sold in the Public Offering. Otherwise, the Sponsor Warrants have terms and provisions that are identical to those of the Public Warrants except that the Sponsor Warrants may be exercised on a cashless basis. If the Company does not complete the Business Combination, then the proceeds will be part of the liquidating distribution to the public stockholders and the Sponsor Warrants issued to the Sponsors will expire worthless. Registration Rights The holders of the Founder Shares, Sponsor Warrants, shares of Class A common stock issuable upon conversion of the Founder Shares, Sponsor Warrants or Working Capital Loans will be entitled to registration rights. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have ‘‘piggy-back’’ registration rights to include their securities in other registration statements filed by the Company. Notwithstanding the foregoing, JFG may not exercise its demand and “piggyback” registration rights after five (5) and seven (7) years, respectively after the effective date of the registration statement relating to the Public Offering and may not exercise its demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Commissions Jefferies LLC is the underwriter of the Public Offering, and its indirect parent, JFG, beneficially owns 48.3% of the Founder Shares. Jefferies LLC received all of the underwriting discount that was due at the closing of the Public Offering, and will receive the additional Deferred Discount payable from the Trust Account upon completion of the Business Combination. See Note 4 for further information regarding underwriting commissions. Administrative Services Agreement The Company entered into an administrative services agreement in which the Company will pay Fertitta Entertainment, Inc., (an affiliate of TJF) for office space, utilities and secretarial and administrative support, in an amount equal to $20,000 per month ending on the earlier of the completion of a Business Combination or October 14, 2022, if the Company is unable to complete the Business Combination. The Company has recorded administrative services fees of $60,000 as of December 31, 2020. Directors’ Payments The Company expects to pay $100,000 to each of our independent directors at the closing of a Business Combination for services rendered as board members prior to the completion of a Business Combination. Sponsor Indemnification The Sponsors have agreed that they will be jointly and severally liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share or (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to see access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the extent of any liability for such third party claims. Sponsor Loans On August 24, 2020, the Sponsors agreed to loan the Company up to an aggregate of $300,000 by the issuance of unsecured promissory notes to cover expenses related to the Public Offering. These loans of $166,750 were repaid in full on October 16, 2020. In addition, the Sponsors will not be prohibited from loaning the Company funds in order to finance transaction costs in connection with the Business Combination. Up to $1,500,000 of these loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Sponsor Warrants. The terms of such loans have not been determined and no written agreements exist with respect to such loans. See Note 4 for the terms of the warrants.

Merger Agreement

Merger Agreement	12 Months Ended
Merger Agreement	Dec. 31, 2020
Merger Agreement
Merger Agreement	7. Merger Agreement On January 24, 2021, the Company’s board of directors unanimously approved an agreement and plan of merger, dated January 24, 2021, by and among Landcadia, Helios Sun Merger Sub, Inc., the Company’s wholly owned subsidiary (“Merger Sub”), HMAN Group Holdings Inc., a Delaware corporation (“Hillman Holdco”) and CCMP Sellers’ Representative, LLC, a Delaware limited liability company in its capacity as the Stockholder Representative thereunder (in such capacity, the “Stockholder Representative”) (as it may be amended and/or restated from time to time, the “Merger Agreement”). If the Merger Agreement is adopted by the Company’s stockholders and the transactions under the Merger Agreement are consummated, Merger Sub will merge with and into Hillman Holdco with Hillman Holdco surviving the merger as the Company’s wholly owned subsidiary (the “Proposed Transaction”). Hillman Holdco is a holding company that indirectly holds all of the issued and outstanding capital stock of The Hillman Group, Inc., which, together with its direct and indirect subsidiaries (Hillman Holdco, The Hillman Group, Inc. and its direct and indirect subsidiaries, collectively, “Hillman” and each such entity, a “Hillman Group Entity”), is in the business of providing hardware-related products and related merchandising services to retail markets in North America. In connection with the consummation of the Proposed Transaction, We will be renamed “Hillman Solutions Corp.” and is referred to herein as “New Hillman” as of the time following such change of name. In accordance with the terms and subject to the conditions of the Merger Agreement, the Company has agreed to pay aggregate consideration in the form of New Hillman common stock (the “Aggregate Consideration”) calculated as described below and equal to a value of approximately (i) $911,300,000 plus (ii) $28,280,000, such amount being the value of 2,828,000 Founder Shares, valued at $10.00 per share that the Sponsors, have agreed to forfeit at the closing of the Proposed Transaction (the “Closing”). At the effective time of the Proposed Transaction, all outstanding shares of common stock of Hillman Holdco will be cancelled in exchange for the right to receive, with respect to each such share, a certain number of shares of New Hillman common stock valued at $10.00 per share equal to (A) (i) the Aggregate Consideration plus (ii) the value that would be received by Hillman Holdco upon the exercise of all outstanding Hillman Holdco options as of immediately prior to the Closing (the “Adjusted Purchase Price”), divided by (B) (i) the total number of shares of Hillman Holdco common stock outstanding as of immediately prior to the Closing plus (ii) the number of shares of Hillman Holdco common stock underlying all then outstanding Hillman Holdco options and shares of Hillman Holdco restricted stock outstanding as of immediately prior to the Closing (the “Adjusted Per Share Merger Value”). At the effective time, each outstanding option to purchase shares of Hillman Holdco common stock (a “Hillman Holdco Option”), whether vested or unvested, will be assumed by New Hillman and will be converted into an option to acquire common stock of New Hillman (“New Hillman Options”) with substantially the same terms and conditions as applicable to the Hillman Holdco Option immediately prior to the effective time (including expiration date, vesting conditions and exercise provisions), except that (i) each such Hillman Holdco Option shall be exercisable for that number of shares of New Hillman common stock equal to the product (rounded down to the nearest whole number) of (A) the number of shares of Hillman Holdco common stock subject to such Hillman Holdco Assumed Option immediately prior the effective time multiplied by (B) the quotient of (1) the Adjusted Per Share Merger Value divided by (2) $10.00 (such quotient, with respect to each Hillman Holdco Option, the “Closing Stock Per Option Amount”), (ii) the per share exercise price for each share of New Hillman common stock issuable upon exercise of the New Hillman Option shall be equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of Hillman Holdco subject to such Hillman Holdco Option immediately prior to the effective time by (B) the Closing Stock Per Option Amount; (iii) the Hillman Holdco Board (or the compensation committee of the Hillman Holdco Board) may appropriately adjust the performance conditions applicable to certain of the New Hillman Options; and (iv) the Hillman Holdco Board (or the compensation committee of the Hillman Holdco Board) may make such other immaterial administrative or ministerial changes to the New Hillman Options as it may determine in good faith are appropriate to effectuate the administration of the New Hillman Options and to ensure consistency with the administrative and ministerial provisions of the New Hillman Incentive Equity Plan; At the effective time, each share of unvested restricted Hillman Holdco common stock will be cancelled and converted into the right to receive a number of shares of restricted New Hillman common stock (“New Hillman Restricted Stock”) equal to the quotient of (a) the Adjusted Per Share Merger Value divided by (b) $10.00 (such quotient, with respect to each share of unvested Hillman Holdco restricted stock, the “Closing Stock Per Restricted Share Amount”) with substantially the same terms and conditions as were applicable to the related share of Hillman Holdco Restricted Stock immediately prior to the effective time (including with respect to vesting and termination-related provisions), except that (i) any per-share repurchase price of such New Hillman Restricted Stock shall be equal to the quotient obtained by dividing (A) the per-share repurchase price applicable to the Hillman Holdco Restricted Stock, by (B) the Closing Stock Per Restricted Share Amount, rounded up to the nearest cent and (ii) the Hillman Holdco Board (or the compensation committee of the Hillman Holdco Board) may make such other immaterial administrative or ministerial changes to the New Hillman Restricted Stock as it may determine in good faith are appropriate to effectuate the administration of the New Hillman Restricted Stock and to ensure consistency with the administrative and ministerial provisions of the New Hillman Incentive Equity Plan. At the effective time, each Hillman Holdco restricted stock unit (each a “Hillman Holdco RSU”) will be assumed by New Hillman and converted into a restricted stock unit in respect of shares of New Hillman common stock (each, a “New Hillman RSU”) with substantially the same terms and conditions as were applicable to such Hillman Holdco RSU immediately prior to the effective time (including with respect to vesting and termination-related provisions), except that (i) each New Hillman RSU shall represent the right to receive (subject to vesting) that number of shares of New Hillman common stock equal to the product (rounded up to the nearest whole number) of the number of shares of Hillman Holdco common stock underlying the Hillman Holdco RSU immediately prior to the effective time multiplied by the quotient of (a) the Adjusted Per Share Merger Value divided by (b) $10.00 (such quotient, with respect to each Hillman Holdco restricted stock unit, the “Hillman Holdco RSU Exchange Ratio”); and (ii) the Hillman Holdco Board (or the compensation committee of the Hillman Holdco Board) may make such other immaterial administrative or ministerial changes to the New Hillman RSUs as it may determine in good faith are appropriate to effectuate the administration of the New Hillman RSUs and to ensure consistency with the administrative and ministerial provisions of the New Hillman Incentive Equity Plan. In addition, pursuant to the A&R Letter Agreement, the Sponsors will, at the Closing of the Proposed Transaction, forfeit a total of 3,828,000 of their Founder Shares (the “Sponsor Forfeited Shares”), with 2,828,000 shares being forfeited by the Sponsors on a basis pro rata with their ownership of the Company and 1,000,000 additional shares being forfeited by the TJF. Immediately prior to the effective time of the Business Combination, with the exception of the Sponsor Forfeited Shares, each of the currently issued and outstanding shares of Landcadia’s Class B common stock will automatically convert, on a one-for-one basis, into shares of Landcadia’s Class A common stock in accordance with the terms of our second amended and restated certificate of incorporation, and thereafter, in connection with the Closing, Landcadia’s Class A common stock will be reclassified as New Hillman common stock.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
Derivative Financial Instruments	Dec. 31, 2020
Derivative Financial Instruments
Derivative Financial Instruments	8. Derivative Financial Instruments In accordance with ASC 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, entities must consider whether to classify contracts that may be settled in its own stock, such as warrants, as equity of the entity or as an asset or liability. If an event that is not within the entity’s control could require net cash settlement, then the contract should be classified as an asset or a liability rather than as equity. We have determined because the terms of Public Warrants include a provision that entitles all warrantholders to cash for their warrants in the event of a qualifying cash tender offer, while only certain of the holders of the underlying shares of common stock would be entitled to cash, our warrants should be classified as a derivative liability measured at fair value, with changes in fair value each period reported in earnings. Volatility in our Common Stock and Public Warrants may result in significant changes in the value of the derivatives and resulting gains and losses on our statement of operations. In conjunction with our Public Offering, which closed October 14, 2020, the Company sold 50,000,000 Units at a price of $10.00 per Unit (the “Public Units”). Each Unit consists of one share of the Company’s Class A common stock, $0.0001 par value and one-third of one redeemable warrant (each a “Public Warrant”) and simultaneously, the Sponsors purchased an aggregate of 8,000,000 Sponsor Warrants at a price of $1.50 per warrant ($12,000,000 in the aggregate) in the Private Placement. As of December 31, 2020, 16,666,667 Public Warrants and 8,000,000 Sponsor Warrants are outstanding. The Sponsor Warrants (including the Class A common stock issuable upon exercise of the Sponsor Warrants) are not transferable, assignable or salable until 30 days after the completion of the Business Combination and they are non-redeemable so long as they are held by the initial purchasers of the Sponsor Warrants or their permitted transferees. If the Sponsor Warrants are held by someone other than the initial purchasers of the Sponsor Warrants or their permitted transferees, the Sponsor Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Otherwise, the Sponsor Warrants have terms and provisions that are identical to those of the Public Warrants except that the Sponsor Warrants may be exercised on a cashless basis. If the Company does not complete the Business Combination, then the proceeds will be part of the liquidating distribution to the public stockholders and the Sponsor Warrants issued to the Sponsors will expire worthless. Because the terms of the Sponsor Warrants and Public Warrants are so similar, we classified both types of warrants as a derivative liability measured at fair value. Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. Each Public Warrant will become exercisable on the later of 30 days after the completion of the Business Combination or 12 months from the closing of the Public Offering. However, if the Company does not complete the Business Combination on or prior to October 14, 2022, the warrants will expire at the end of such period. If the Company is unable to deliver registered shares of Class A common stock to the holder upon exercise of Public Warrants issued in connection with the Units during the exercise period, there will be no net cash settlement of these Public Warrants and the Public Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the warrant agreement. Once the Public Warrants become exercisable, the Company may call the warrants for redemption: (i) in whole and not in part; (ii) at a price of $0.01 per warrant; (iii) upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and (iv) if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. The Company determined, at the time of the Public Offering, the initial value of its Public Warrants and Sponsor Warrants were $18,830,000 and $9,200,000, respectively. As of December 31, 2020, the value of our Public Warrants and Sponsor Warrants were $37,000,000 and $18,720,000, respectively. As of December 31, 2020, we recorded a change in fair value of warrant derivative liability of $27,690,000 in other income and expense on our statement of operations. For further information on our warrants, see Notes 5 and 6.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2020
Fair Value Measurements
Fair Value Measurements	9. Fair Value Measurements Fair value is measured based on an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions market participants would use in pricing an asset or liability. Assets and liabilities measured at fair value are based on a market valuation approach using prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. As a basis for considering such assumptions, a three-tiered fair value hierarchy is established, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets that are observable, either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. Management determined that the fair value of each Sponsor Warrant is the same as that of a Public Warrant, with an insignificant adjustment for short-term marketability restrictions. Accordingly, at December 31, 2020 the Public Warrants are classified as Level 1 financial instruments and the Sponsor Warrants are classified as Level 2 financial instruments. The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Fair Value measured as of December 31, 2020 Level 1 Level 2 Level 3 Total Cash and Marketable Securities Held in Trust $ 500,078,624 $ — $ — $ 500,078,624 Warrant derivative liability Public Warrants $ 37,000,000 $ — $ — $ 37,000,000 Sponsor Warrants — 18,720,000 — 18,720,000 Total Warrant derivative liability $ 37,000,000 $ 18,720,000 $ — $ 55,720,000 The Company determined on the date of the Public Offering, October 14, 2020, the initial value of its Public Warrants and Sponsor Warrants to be $18,830,000 and $9,200,000, respectively. The Public Warrants were valued using the Monte Carlo method and the Sponsor Warrants were valued using the Black-Scholes-Merton model. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. Key assumptions included (1) 0.38% risk-free interest rate, (2) unit price of $9.96 (3) common stock price of $9.58 (4) expected term of 0.75 year (5) volatility of 19.0% and (6) zero expected dividends. Based on these assumptions, the initial fair value was $1.13 per Public Warrant and $1.15 per Sponsor Warrant. On November 27, 2020 the Public Warrants began trading on the on NASDAQ under the symbol “LCYAW”. Because quoted prices in an active market could be established (Level 1 Fair Value), the Company transferred all of the Public and Sponsor Warrants out of Level 3 and into Levels 1 and 2 respectively.

Loss Per Common Share

Loss Per Common Share	12 Months Ended
Loss Per Common Share	Dec. 31, 2020
Loss Per Common Share
Loss Per Common Share	10. Loss Per Common Share A reconciliation of the numerators and denominators for the basic and diluted per common share amounts is as follows: For the period from March 13, 2018 (inception) Twelve months ended December 31, through 2020 2019 December 31, 2018 Numerator: Net loss - basic and diluted $ (28,890,395) $ — $ — Less: Income attributable to common stock subject to possible redemption (6,913) — — Net loss available to common shares $ (28,897,308) $ — $ — Demoninator: Weighted average number of shares - basic 9,654,569 6,037,500 6,037,500 Warrants — — — Weighted average number of shares - diluted 9,654,569 6,037,500 6,037,500 Basic and diluted loss available to common shares $ (2.99) $ — $ — All shares of Class B common stock are assumed to convert to shares of Class A common stock on a one-for-one basis.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2020
Income Taxes
Income Taxes	11. Income Taxes A reconciliation of the income tax expense (benefit) is as follows: For the period from March 13, 2018 (inception) Year ended December 31, through 2020 2019 December 31, 2018 Current income taxes $ — $ — $ — Deferred income taxes — — — Income tax expense (benefit) $ — $ — $ — The Company’s deferred tax assets are as follows: Year ended December 31, 2020 2019 Deferred tax asset: Net operating loss carryforward $ 32,400 $ — Total deferred tax asset $ 32,400 $ — Valuation allowance (32,400) — Deferred tax asset, net of current allowance $ — $ — A reconciliation of the federal income tax statutory rate to the Company’s effective tax rate is as follows: For the period from March 13, 2018 Year ended December 31, (inception) through 2020 2019 December 31, 2018 Income tax benefit at statutory rate (21.0%) $ (6,066,983) $ — $ — Change in fair value of warrant liability 5,814,900 — — Offering costs 219,683 — — Change in valuation allowance on deferred tax asset 32,400 — — Total — — — Effective tax rate % 21.0 % 21.0 % In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2020, the change in the valuation allowance was $32,400. As of December 31, 2020, the Company had $154,280 of U.S. federal net operating loss carryovers available to offset future taxable income. The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company’s tax returns for 2020 remain open and subject to examination. The Company considers Texas to be a significant state tax jurisdiction.

Selected Quarterly Financial Da

Selected Quarterly Financial Data (unaudited)	12 Months Ended
Selected Quarterly Financial Data (unaudited)	Dec. 31, 2020
Selected Quarterly Financial Data (unaudited)
Selected Quarterly Financial Data (unaudited)	12. Selected Quarterly Financial Data (unaudited) Quarterly financial data for 2020, 2019 and 2018 is as follows: 2020 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter General and administrative expenses $ — $ — $ — $ 1,279,019 Net income (loss) $ — $ — $ — $ (28,890,395) Basic and diluted earnings (loss) available to common shares $ — $ — $ — $ (1.63) 2019 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter General and administrative expenses $ — $ — $ — $ — Net income (loss) $ — $ — $ — $ — Basic and diluted earnings (loss) available to common shares $ — $ — $ — $ — Period from March 13, 2018 (inception) through December 31, 2018 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter General and administrative expenses $ — $ — $ — $ — Net income (loss) $ — $ — $ — $ — Basic and diluted earnings (loss) available to common shares $ — $ — $ — $ —

Schedule II Valuation of Qualif

Schedule II Valuation of Qualifying Accounts	12 Months Ended
Schedule II Valuation of Qualifying Accounts	Dec. 31, 2020
Schedule II Valuation of Qualifying Accounts
Schedule II Valuation of Qualifying Accounts	Schedule II Valuation of Qualifying Accounts Balance at Charges Beginning of Charges (credits) (credits) to Balance at Description Period to expense other accounts Write-offs End of Period Deferred tax valuation allowance: December 31, 2020 $ — $ 32,400 $ — $ — $ 32,400 December 31, 2019 $ — $ — $ — $ — $ — December 31, 2018 $ — $ — $ — $ — $ —

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2020
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying financial statements include the accounts of the Company and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).
Use of Estimates	Use of Estimates The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards used.
Cash and Cash equivalents	Cash and Cash equivalents The Company considers cash equivalents to be all short-term investments with an original maturity of three months or less when purchased. The Company did not have any cash equivalents as of December 31, 2020 and 2019. Cash consists of proceeds from the Public Offering and Private Placement held outside of the Trust Account and may be used to pay for business, legal and accounting due diligence for the Business Combination and continuing general and administrative expenses.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts with a financial institution which may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and the Company believes that it is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company classifies financial instruments under FASB ASC 820, “Fair Value Measurement,” for its financial assets and liabilities that are reported at fair value at each reporting period. The carrying value of the Company’s cash and cash equivalents, and accrued liabilities, approximates their fair value due to the short-term nature of such instruments. Our financial instruments that are subject to fair value measurements consist of our warrant derivative liability. Fair value is measured based on an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions market participants would use in pricing an asset or liability. Assets and liabilities measured at fair value are based on a market valuation approach using prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. As a basis for considering such assumptions, a three-tiered fair value hierarchy is established, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets that are observable, either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. See Note 9 for further information.
Offering Costs	Offering Costs Total offering costs were $775,000 and consisted of legal, accounting, other costs incurred in connection with the formation and preparation of the Public Offering. Underwriting commissions for the Public Offering were $27,500,000, of which $17,500,000 have been deferred until the completion of the Business Combination. Because the Public Warrants have been accounted for as a liability at fair value instead of equity, the Company applied the relative fair value method and allocated a portion of offering costs and underwriting commissions to expenses with the remainder charged to additional paid in capital at the closing of the Offering.
Accounts Payable and Accrued Liabilities	Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities were $127,450 as of December 31, 2020, and primarily consist of Delaware franchise tax expenses and costs incurred for the formation and preparation of the Public Offering with corresponding amounts charged to Offering costs.
Warrant Liabilities	Warrant Liabilities In accordance with ASC 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, entities must consider whether to classify contracts that may be settled in its own stock, such as warrants, as equity of the entity or as an asset or liability. If an event that is not within the entity’s control could require net cash settlement, then the contract should be classified as an asset or a liability rather than as equity. We have determined because the terms of Public Warrants include a provision that entitles all warrantholders to cash for their warrants in the event of a qualifying cash tender offer, while only certain of the holders of the underlying shares of common stock would be entitled to cash, our warrants should be classified as liability measured at fair value, with changes in fair value each period reported in earnings. Volatility in our Common Stock and Public Warrants may result in significant changes in the value of the derivatives and resulting gains and losses on our statement of operations.
Loss Per Common Share	Loss Per Common Share Basic loss per common share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding during the period. All shares of Class B common stock are assumed to convert to shares of Class A common stock on a one-for-one basis. Consistent with FASB ASC 480, shares of Class A common stock subject to possible redemption, as well as their pro rata share of undistributed trust earnings consistent with the two-class method, have been excluded from the calculation of loss per common share for the years ended December 31, 2020, 2019 and the period from March 13, 2018 (inception) to December 31, 2018. Such shares, if redeemed, only participate in their pro rata share of trust earnings, see Note 3. Diluted loss per share includes the incremental number of shares of common stock to be issued in connection with the conversion of Class B common stock or to settle warrants, as calculated using the treasury stock method. For the years ended December 31, 2020, 2019 and the period from March 13, 2018 (inception) to December 31, 2018, the Company did not have any dilutive warrants, securities or other contracts that could, potentially, be exercised or converted into common stock. As a result, diluted loss per common share is the same as basic loss per common share for all periods presented. Further, in accordance with FASB ASC 260, the loss per share calculation reflects the effect of the stock splits as discussed in Note 4 for all periods presented. See Note 10 for further information.
Income Taxes	Income Taxes The Company was taxed as a limited liability company prior to August 24, 2020, therefore all tax implications were the responsibility of its member As of August 24, 2020 the Company elected to be taxes as a C Corporation. The Company complies with the accounting and reporting requirements of FASB ASC, 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. There were no unrecognized tax benefits as of December 31, 2020, 2019 and 2018. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at December 31, 2020, 2019 and 2018. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. See Note 11 for further information.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting (Tables)	12 Months Ended
	Dec. 31, 2020
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Summary of effect of the restatement on each financial statements	As previously reported Adjustment As restated Balance Sheet as of October 14, 2020 Warrant derivative liability $ — $ 28,030,000 $ 28,030,000 Total liabilities 19,092,923 28,030,000 47,122,923 Class A common stock subject to possible redemption 477,874,167 (28,030,000) 449,844,167 Class A commmon stock 221 281 502 Additional paid-in capital 5,002,872 1,045,834 6,048,706 Accumulated deficit (2,451) (1,046,115) (1,048,566) Balance Sheet as of December 31, 2020 Warrant derivative liability $ — $ 55,720,000 $ 55,720,000 Total liabilities 17,627,450 55,720,000 73,347,450 Class A common stock subject to possible redemption 478,574,408 (55,720,000) 422,854,408 Class A commmon stock 215 557 772 Additional paid-in capital 5,152,825 28,735,558 33,888,383 Accumulated deficit (154,280) (28,736,115) (28,890,395) Statement of Operations as of December 31, 2020 General and administrative expenses $ (232,904) $ (1,046,115) $ (1,279,019) Change in fair value of warrant derivative liability — (27,690,000) (27,690,000) Total other income (expense) 78,624 (27,690,000) (27,611,376) Net loss (154,280) (28,736,115) (28,890,395) Basic and diluted loss per share (0.02) (2.97) (2.99) Statement of Cash Flows as of December 31, 2020 Net loss $ (154,280) $ (28,736,115) $ (28,890,395) Change in fair value of warrant derivative liability — (27,690,000) (27,690,000) Net cash used in operating activities (211,292) (1,046,115) (1,257,407) Payment for underwriting discounts (10,000,000) 1,046,115 (8,953,885) Net cash provided by financing activites 501,228,698 1,046,115 502,274,813

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2020
Fair Value Measurements
Summary of assets and liabilities that are measured at fair value on a recurring basis	Fair Value measured as of December 31, 2020 Level 1 Level 2 Level 3 Total Cash and Marketable Securities Held in Trust $ 500,078,624 $ — $ — $ 500,078,624 Warrant derivative liability Public Warrants $ 37,000,000 $ — $ — $ 37,000,000 Sponsor Warrants — 18,720,000 — 18,720,000 Total Warrant derivative liability $ 37,000,000 $ 18,720,000 $ — $ 55,720,000

Loss Per Common Share (Tables)

Loss Per Common Share (Tables)	12 Months Ended
Loss Per Common Share (Tables)	Dec. 31, 2020
Loss Per Common Share
Schedule of reconciliation of the numerators and denominators for the basic and diluted per common share	For the period from March 13, 2018 (inception) Twelve months ended December 31, through 2020 2019 December 31, 2018 Numerator: Net loss - basic and diluted $ (28,890,395) $ — $ — Less: Income attributable to common stock subject to possible redemption (6,913) — — Net loss available to common shares $ (28,897,308) $ — $ — Demoninator: Weighted average number of shares - basic 9,654,569 6,037,500 6,037,500 Warrants — — — Weighted average number of shares - diluted 9,654,569 6,037,500 6,037,500 Basic and diluted loss available to common shares $ (2.99) $ — $ —

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2020
Income Taxes
Schedule of reconciliation of income tax expense (benefit)	For the period from March 13, 2018 (inception) Year ended December 31, through 2020 2019 December 31, 2018 Current income taxes $ — $ — $ — Deferred income taxes — — — Income tax expense (benefit) $ — $ — $ —
Schedule of deferred tax assets	Year ended December 31, 2020 2019 Deferred tax asset: Net operating loss carryforward $ 32,400 $ — Total deferred tax asset $ 32,400 $ — Valuation allowance (32,400) — Deferred tax asset, net of current allowance $ — $ —
Schedule of reconciliation of federal income tax statutory rate to Company's effective tax rate	For the period from March 13, 2018 Year ended December 31, (inception) through 2020 2019 December 31, 2018 Income tax benefit at statutory rate (21.0%) $ (6,066,983) $ — $ — Change in fair value of warrant liability 5,814,900 — — Offering costs 219,683 — — Change in valuation allowance on deferred tax asset 32,400 — — Total — — — Effective tax rate % 21.0 % 21.0 %

Selected Quarterly Financial _2

Selected Quarterly Financial Data (unaudited) (Tables)	12 Months Ended
Selected Quarterly Financial Data (unaudited) (Tables)	Dec. 31, 2020
Selected Quarterly Financial Data (unaudited)
Schedule of selected quarterly financial data (unaudited)	2020 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter General and administrative expenses $ — $ — $ — $ 1,279,019 Net income (loss) $ — $ — $ — $ (28,890,395) Basic and diluted earnings (loss) available to common shares $ — $ — $ — $ (1.63) 2019 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter General and administrative expenses $ — $ — $ — $ — Net income (loss) $ — $ — $ — $ — Basic and diluted earnings (loss) available to common shares $ — $ — $ — $ — Period from March 13, 2018 (inception) through December 31, 2018 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter General and administrative expenses $ — $ — $ — $ — Net income (loss) $ — $ — $ — $ — Basic and diluted earnings (loss) available to common shares $ — $ — $ — $ —

Schedule II Valuation of Qual_2

Schedule II Valuation of Qualifying Accounts (Tables)	12 Months Ended
Schedule II Valuation of Qualifying Accounts (Tables)	Dec. 31, 2020
Schedule II Valuation of Qualifying Accounts
Schedule II Valuation of Qualifying Accounts	Balance at Charges Beginning of Charges (credits) (credits) to Balance at Description Period to expense other accounts Write-offs End of Period Deferred tax valuation allowance: December 31, 2020 $ — $ 32,400 $ — $ — $ 32,400 December 31, 2019 $ — $ — $ — $ — $ — December 31, 2018 $ — $ — $ — $ — $ —

Nature of Business (Details)

Nature of Business (Details) - USD ($)	Oct. 14, 2020	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Nature Of Business [Line Items]
Number of units issued \| shares			50,000,000
Warrant exercise price			$ 11.50
Proceeds from public offering			$ 500,000,000	$ 0
Proceeds from sale of private placement warrants			12,000,000	0
Maximum amount of interest to pay dissolution expenses			100,000
Tax benefit (provision)		$ 0	$ 0	0
Percentage refers to fair market value of business transaction			80.00%
Percentage of outstanding voting securities			50.00%
Net tangible assets			$ 5,000,001
Percentage refers to redemption of shares if no business combination occurs			15.00%
Investment held in trust account			$ 500,000,000	$ 0
Public Offering
Nature Of Business [Line Items]
Proceeds from sale of stock	$ 500,000,000
Number of units issued \| shares	50,000,000		50,000,000
Price per unit	$ 10
Percentage of public shares redeemed			100.00%
Share price			$ 10
Investment held in trust account			$ 500,000,000
Private placement
Nature Of Business [Line Items]
Proceeds from sale of stock	$ 12,000,000
Proceeds from warrants outstanding	$ 12,000,000
Aggregate sponsor warrants	8,000,000
Warrant exercise price	$ 1.50

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting - Balance sheet (Details) - USD ($)	1 Months Ended	3 Months Ended											10 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019	Oct. 14, 2020
Balance Sheet
Warrant derivative liability		$ 55,720,000				$ 0								$ 55,720,000	$ 0	$ 28,030,000
Total liabilities		73,347,450				0								73,347,450	0	47,122,923
Class A common stock subject to possible redemption		422,854,408				0								422,854,408	0	449,844,167
Additional paid-in capital		33,888,383				306								33,888,383	306	6,048,706
Accumulated deficit		(28,890,395)				0								(28,890,395)	0	(1,048,566)
Statement of Operations
General and administrative expenses	$ 0	(1,279,019)	$ 0	$ 0	$ 0	0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	(1,279,019)	0
Change in fair value of warrant derivative liability													0	(27,690,000)	0
Total other income (expense)													0	(27,611,376)	0
Net loss	$ 0	$ (28,890,395)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ (28,890,395)	$ 0
Basic and diluted loss available to common shares	$ 0	$ (1.63)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ (2.99)	$ 0
Statement of Cash Flows
Net loss	$ 0	$ (28,890,395)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ (28,890,395)	$ 0
Change in fair value of warrant derivative liability													$ 0	(27,690,000)	0
Net cash used in operating activities														(1,257,407)	0
Payment for underwriting discounts														(8,953,885)	0
Net cash provided by financing activites														502,274,813	0
Restatement of warrants as derivative liabilities
Balance Sheet
Warrant derivative liability		55,720,000												55,720,000
Statement of Operations
Change in fair value of warrant derivative liability														(28,030,000)
Statement of Cash Flows
Change in fair value of warrant derivative liability														(28,030,000)
As previously reported \| Restatement of warrants as derivative liabilities
Balance Sheet
Warrant derivative liability		0												0		0
Total liabilities		17,627,450												17,627,450		19,092,923
Class A common stock subject to possible redemption		478,574,408												478,574,408		477,874,167
Additional paid-in capital		5,152,825												5,152,825		5,002,872
Accumulated deficit		(154,280)												(154,280)		(2,451)
Statement of Operations
General and administrative expenses														(232,904)
Change in fair value of warrant derivative liability														0
Total other income (expense)														78,624
Net loss														$ (154,280)
Basic and diluted loss available to common shares														$ (0.02)
Statement of Cash Flows
Net loss														$ (154,280)
Change in fair value of warrant derivative liability														0
Net cash used in operating activities														(211,292)
Payment for underwriting discounts														(10,000,000)
Net cash provided by financing activites														501,228,698
Adjustment \| Restatement of warrants as derivative liabilities
Balance Sheet
Warrant derivative liability		55,720,000												55,720,000		28,030,000
Total liabilities		55,720,000												55,720,000		28,030,000
Class A common stock subject to possible redemption		(55,720,000)												(55,720,000)		(28,030,000)
Additional paid-in capital		28,735,558												28,735,558		1,045,834
Accumulated deficit		(28,736,115)												(28,736,115)		(1,046,115)
Statement of Operations
General and administrative expenses														(1,046,115)
Change in fair value of warrant derivative liability														(27,690,000)
Total other income (expense)														(27,690,000)
Net loss														$ (28,736,115)
Basic and diluted loss available to common shares														$ (2.97)
Statement of Cash Flows
Net loss														$ (28,736,115)
Change in fair value of warrant derivative liability														(27,690,000)
Net cash used in operating activities														(1,046,115)
Payment for underwriting discounts														1,046,115
Net cash provided by financing activites														1,046,115
Class A common stock
Balance Sheet
Common stock		772				$ 0								772	$ 0	502
Class A common stock \| As previously reported \| Restatement of warrants as derivative liabilities
Balance Sheet
Common stock		215												215		221
Class A common stock \| Adjustment \| Restatement of warrants as derivative liabilities
Balance Sheet
Common stock		$ 557												$ 557		$ 281

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting (Details) - USD ($)	Oct. 14, 2020	Mar. 31, 2018	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Warrant liability	$ 28,030,000		$ 55,720,000				$ 0								$ 55,720,000	$ 0
Change in fair value of warrant derivative liability														$ 0	27,690,000	0
Units issued value															481,170,000
General and administrative expenses		$ 0	1,279,019	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	1,279,019	$ 0
Public Offering
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Units issued value	500,000,000
Public Warrants
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Warrant liability			$ 37,000,000												$ 37,000,000
Public Warrants \| Public Offering
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Warrant liability	18,830,000
Percentage of fair value to total public warrants			3.70%												3.70%
General and administrative expenses			$ 1,046,115
Sponsor Warrant
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Warrant liability			18,720,000												$ 18,720,000
Sponsor Warrant \| Public Offering
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Warrant liability	9,200,000
Restatement of warrants as derivative liabilities
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Warrant liability			55,720,000												55,720,000
Change in fair value of warrant derivative liability															28,030,000
Restatement of warrants as derivative liabilities \| Adjustment
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Warrant liability	28,030,000		$ 55,720,000												55,720,000
Change in fair value of warrant derivative liability															27,690,000
General and administrative expenses															$ 1,046,115
Common Stock \| Public Offering
Restatement of Previously Issued Financial Statements to Reflect Derivative Accounting
Warrant liability	$ 481,170,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	1 Months Ended	12 Months Ended
Summary of Significant Accounting Policies (Details)	Jan. 24, 2021	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Summary of Significant Accounting Policies
Federal depository insurance coverage		$ 250,000
Offering Costs		775,000
Underwriting discount		27,500,000
Deferred underwriters commission		17,500,000
Accounts payable and accrued liabilities		$ 127,450	$ 0
Conversion ratio	1

Stockholder's Equity (Details)

Stockholder's Equity (Details) - USD ($)	Oct. 14, 2020	Sep. 16, 2020	Aug. 24, 2020	Mar. 13, 2018	Dec. 31, 2020	Dec. 31, 2019
Class of Stock [Line Items]
Membership interest acquired					50.00%
Common stock authorized			401,000,000
Preferred stock authorized			1,000,000		1,000,000
Preferred stock par value (in dollars per share)			$ 0.0001		$ 0.0001
Stock split description of founders shares		1:1.25
Number Of Shares Subject To Forfeiture					1,875,000
Invested capital					$ 2,070
Number of units issued \| shares					50,000,000
Net tangible asset threshold					$ 5,000,001
Redeemable Shares outstanding					42,278,793
Founders shares
Class of Stock [Line Items]
Common stock issued		14,375,000
JFG \| JFG
Class of Stock [Line Items]
Membership interest acquired				100.00%
Consideration for acquisition of membership interest				$ 1,000
TJF
Class of Stock [Line Items]
Membership interest acquired			51.70%
Consideration for acquisition of membership interest			$ 1,070
JFG and TJF
Class of Stock [Line Items]
Common stock outstanding					12,500,000
Public Offering
Class of Stock [Line Items]
Number of units issued \| shares	50,000,000				50,000,000
Class A common stock
Class of Stock [Line Items]
Common stock authorized			380,000,000		380,000,000
Common stock par value (in dollars per share)			$ 0.0001		$ 0.0001
Common stock issued					7,721,207
Common stock outstanding					7,721,207
Redeemable Shares outstanding					42,278,793
Class B common stock
Class of Stock [Line Items]
Common stock authorized			20,000,000		20,000,000	20,000,000
Common stock par value (in dollars per share)			$ 0.0001		$ 0.0001	$ 0.0001
Number of shares held by sponsors			11,500,000
Common stock issued					12,500,000	12,500,000

Public Offering (Details)

Public Offering (Details)	Oct. 14, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Aug. 24, 2020$ / shares
Subsidiary or Equity Method Investee [Line Items]
Number of units issued \| shares \| shares		50,000,000
Number Of Business Days		15 days
Warrant exercise price		$ 11.50
Warrant exercisable term, after the completion of the Business Combination		30 days
Warrant exercisable term, from the closing of the public offering		12 months
Warrant expiration term		24 months
Warrants redemption description		the warrants for redemption: (i) in whole and not in part; (ii) at a price of $0.01 per warrant; (iii) upon not less than 30 days' prior written notice of redemption to each warrant holder; and (iv) if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 value per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.
Warrant Redemption period		30 days
Underwriting discount \| $		$ 27,500,000
Class A common stock
Subsidiary or Equity Method Investee [Line Items]
Common stock par value (in dollars per share)		$ 0.0001	$ 0.0001
Closing share price		$ 18
Public Offering
Subsidiary or Equity Method Investee [Line Items]
Number of units issued \| shares \| shares	50,000,000	50,000,000
Price per unit	$ 10
Warrant Convertible Ratio	0.33
Closing share price		$ 10
Underwriting discount \| $	$ 10,000,000
Underwriting discount per unit	0.20
Additional fee deferred discount \| $	$ 17,500,000
Additional fee deferred discount per unit	0.35

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Oct. 14, 2020	Aug. 24, 2020	Dec. 31, 2020	Oct. 16, 2020
Related Party Transaction [Line Items]
Warrant exercise price			$ 11.50
Restriction to transfer sponsor warrants			The Sponsor Warrants (including the Class A common stock issuable upon exercise of the Sponsor Warrants) are not transferable, assignable or salable until 30 days after the completion of the Business Combination and they are non-redeemable so long as they are held by the initial purchasers of the Sponsor Warrants or their permitted transferees.
Sponsor indemnification description			The Sponsors have agreed that they will be jointly and severally liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share or (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to see access to the Trust Account and except as to any claims under the Company's indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsors will not be responsible to the extent of any liability for such third party claims.
Maximum amount of loan convertible in to warrants		$ 1,500,000
Warrant exercise price for conversion of loan		$ 1.50
Directors'
Related Party Transaction [Line Items]
Administrative services fees			$ 100,000
Sponsor Warrants
Related Party Transaction [Line Items]
Warrant exercise price			$ 11.50
Public Offering
Related Party Transaction [Line Items]
Proceeds from sale of stock	$ 500,000,000
Private placement
Related Party Transaction [Line Items]
Aggregate sponsor warrants	8,000,000
Warrant exercise price	$ 1.50
Proceeds from warrants outstanding	$ 12,000,000
Proceeds from sale of stock	$ 12,000,000
Founders shares
Related Party Transaction [Line Items]
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			20.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination			1 year
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination			20 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination			30 days
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences			150 days
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)			$ 12
Founders shares \| Class A common stock
Related Party Transaction [Line Items]
Stock conversion ratio			1
Founders shares \| Jefferies LLC [Member]
Related Party Transaction [Line Items]
Ownership percentage of initial stockholders			48.30%
Fertitta Entertainment, Inc
Related Party Transaction [Line Items]
Administrative services fees			$ 60,000
Per month payment for office space, utilities and secretarial and administrative support			$ 20,000
Fertitta Entertainment, Inc \| Administrative services agreement
Related Party Transaction [Line Items]
Maximum amount of unsecured promissory note outstanding form sponsors		$ 300,000
Sponsor
Related Party Transaction [Line Items]
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			22.40%
Notes payable, affiliates				$ 166,750

Merger Agreement (Details)

Merger Agreement (Details)	1 Months Ended
Merger Agreement (Details)	Jan. 24, 2021USD ($)$ / sharesshares
Business Acquisition [Line Items]
Threshold Conversion Ratio of Stock	1
Merger agreement
Business Acquisition [Line Items]
Aggregate cash consideration \| $	$ 911,300,000
Value of founder shares, consideration \| $	$ 28,280,000
Number of founder shares issued, consideration	2,828,000
Acquisition value per share \| $ / shares	$ 10
Adjusted merger value per share \| $ / shares	$ 10
Threshold Conversion Ratio of Stock	1
Merger agreement \| Sponsor
Business Acquisition [Line Items]
Number of shares to be forfeited under A&R agreement	3,828,000
Number of shares forfeited	2,828,000
Merger agreement \| TJF
Business Acquisition [Line Items]
Number of shares forfeited	1,000,000

Derivative Financial Instrume_2

Derivative Financial Instruments (Details)	Oct. 14, 2020USD ($)$ / sharesshares	Dec. 31, 2018USD ($)	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)	Aug. 24, 2020$ / shares
Derivative Financial Instruments
Number of units issued \| shares \| shares			50,000,000
Warrant exercise price \| $ / shares			$ 11.50
Restriction to transfer sponsor warrants			The Sponsor Warrants (including the Class A common stock issuable upon exercise of the Sponsor Warrants) are not transferable, assignable or salable until 30 days after the completion of the Business Combination and they are non-redeemable so long as they are held by the initial purchasers of the Sponsor Warrants or their permitted transferees.
Warrants redemption description			the warrants for redemption: (i) in whole and not in part; (ii) at a price of $0.01 per warrant; (iii) upon not less than 30 days' prior written notice of redemption to each warrant holder; and (iv) if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 value per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.
Warrant exercisable term, after the completion of the Business Combination			30 days
Warrant exercisable term, from the closing of the public offering			12 months
Warrant liability	$ 28,030,000		$ 55,720,000	$ 0
Change in fair value of warrant derivative liability		$ 0	$ 27,690,000	$ 0
Public Offering
Derivative Financial Instruments
Number of units issued \| shares \| shares	50,000,000		50,000,000
Price per unit \| $ / shares	$ 10
Warrant Convertible Ratio	0.33
Private placement
Derivative Financial Instruments
Aggregate warrants \| shares	8,000,000
Warrant exercise price \| $ / shares	$ 1.50
Proceeds from warrants outstanding	$ 12,000,000
Class A common stock
Derivative Financial Instruments
Common stock par value (in dollars per share) \| $ / shares			$ 0.0001		$ 0.0001
Public Warrants
Derivative Financial Instruments
Aggregate warrants \| shares			16,666,667
Warrant liability			$ 37,000,000
Public Warrants \| Public Offering
Derivative Financial Instruments
Warrant liability	18,830,000
Sponsor Warrant
Derivative Financial Instruments
Aggregate warrants \| shares			8,000,000
Warrant liability			$ 18,720,000
Sponsor Warrant \| Public Offering
Derivative Financial Instruments
Warrant liability	$ 9,200,000

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	Dec. 31, 2020	Oct. 14, 2020	Dec. 31, 2019
Fair Value Measurements
Warrant derivative liability	$ 55,720,000	$ 28,030,000	$ 0
Recurring
Fair Value Measurements
Cash and Marketable Securities Held in Trust	500,078,624
Warrant derivative liability	55,720,000
Recurring \| Level 1
Fair Value Measurements
Cash and Marketable Securities Held in Trust	500,078,624
Warrant derivative liability	37,000,000
Recurring \| Level 2
Fair Value Measurements
Warrant derivative liability	18,720,000
Public Warrants
Fair Value Measurements
Warrant derivative liability	37,000,000
Public Warrants \| Recurring
Fair Value Measurements
Warrant derivative liability	37,000,000
Public Warrants \| Recurring \| Level 1
Fair Value Measurements
Warrant derivative liability	37,000,000
Sponsor Warrant
Fair Value Measurements
Warrant derivative liability	18,720,000
Sponsor Warrant \| Recurring
Fair Value Measurements
Warrant derivative liability	18,720,000
Sponsor Warrant \| Recurring \| Level 2
Fair Value Measurements
Warrant derivative liability	$ 18,720,000

Fair Value Measurements (Deta_2

Fair Value Measurements (Details)	Dec. 31, 2020USD ($)	Oct. 14, 2020USD ($)Y$ / shares	Dec. 31, 2019USD ($)
Fair Value Measurements
Warrant liability	$ 55,720,000	$ 28,030,000	$ 0
Public Warrants
Fair Value Measurements
Warrant liability	37,000,000
Sponsor Warrant
Fair Value Measurements
Warrant liability	$ 18,720,000
Public Offering \| Public Warrants
Fair Value Measurements
Warrant liability		18,830,000
Public Offering \| Sponsor Warrant
Fair Value Measurements
Warrant liability		$ 9,200,000
Level 3 \| Public Offering \| Risk-free interest rate
Fair Value Measurements
Unobservable inputs		0.38
Level 3 \| Public Offering \| Unit price
Fair Value Measurements
Unobservable inputs \| $ / shares		9.96
Level 3 \| Public Offering \| Common stock price
Fair Value Measurements
Unobservable inputs \| $ / shares		9.58
Level 3 \| Public Offering \| Expected term
Fair Value Measurements
Unobservable inputs \| Y		0.75
Level 3 \| Public Offering \| volatility
Fair Value Measurements
Unobservable inputs		19
Level 3 \| Public Offering \| Expected dividends
Fair Value Measurements
Unobservable inputs		0
Level 3 \| Public Offering \| Public Warrants
Fair Value Measurements
Fair value per warrant \| $ / shares		$ 1.13
Level 3 \| Public Offering \| Sponsor Warrant
Fair Value Measurements
Fair value per warrant \| $ / shares		$ 1.15

Loss Per Common Share (Details)

Loss Per Common Share (Details) - USD ($)	1 Months Ended	3 Months Ended											10 Months Ended	12 Months Ended
Loss Per Common Share (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Numerator:
Net income (loss) - basic and diluted	$ 0	$ (28,890,395)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ (28,890,395)	$ 0
Less: Income attributable to common stock subject to possible redemption													0	(6,913)	0
Net loss available to common shares													$ 0	$ (28,897,308)	$ 0
Denominator:
Weighted average number of shares - basic													6,037,500	9,654,569	6,037,500
Warrants													0	0	0
Weighted average number of shares - diluted													6,037,500	9,654,569	6,037,500
Basic and diluted loss available to common shares	$ 0	$ (1.63)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ (2.99)	$ 0

Loss Per Common Share - Additio

Loss Per Common Share - Additional information (Details)	1 Months Ended	12 Months Ended
Loss Per Common Share - Additional information (Details)	Jan. 24, 2021	Dec. 31, 2020
Antidilutive securities excluded from computation of earnings per share
Threshold Conversion Ratio of Stock	1
Class A common stock
Antidilutive securities excluded from computation of earnings per share
Threshold Conversion Ratio of Stock		1

Income Taxes - Income tax expen

Income Taxes - Income tax expense (benefit) (Details) - USD ($)	10 Months Ended	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of income tax expense (benefit)
Current income taxes	$ 0	$ 0	$ 0
Deferred income taxes	0	0	0
Income tax expense (benefit)	$ 0	$ 0	$ 0

Income Taxes - Deferred tax ass

Income Taxes - Deferred tax assets (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Mar. 12, 2018
Deferred tax asset:
Net operating loss carryforward	$ 32,400	$ 0
Total deferred tax asset	32,400	0
Valuation allowance	(32,400)	0	$ 0	$ 0
Deferred tax asset, net of current allowance	$ 0	$ 0

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of income tax rate to effective tax rate (Details) - USD ($)	10 Months Ended	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Income Taxes
Income tax benefit at statutory rate (21.0%)		$ (6,066,983)
Change in fair value of warrant liability		5,814,900
Offering costs		219,683
Change in valuation allowance on deferred tax asset		32,400
Income tax expense (benefit)	$ 0	$ 0	$ 0
Statutory rate		21.00%
Effective tax rate	21.00%	0.00%	21.00%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details)	12 Months Ended
Income Taxes - Additional Information (Details)	Dec. 31, 2020USD ($)
Income Taxes
Change in valuation allowance	$ 32,400
Operating Loss Carryforwards	$ 154,280

Selected Quarterly Financial _3

Selected Quarterly Financial Data (unaudited) (Details) - USD ($)	1 Months Ended	3 Months Ended											10 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Selected Quarterly Financial Data (unaudited)
General and administrative expenses	$ 0	$ 1,279,019	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 1,279,019	$ 0
Net income (loss)	$ 0	$ (28,890,395)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ (28,890,395)	$ 0
Basic and diluted loss available to common shares	$ 0	$ (1.63)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ (2.99)	$ 0

Schedule II Valuation of Qual_3

Schedule II Valuation of Qualifying Accounts (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Schedule II Valuation of Qualifying Accounts
Balance at Beginning of Period	$ 0	$ 0
Charges (credits) to expense	32,400	0	$ 0
Charges (credits) to other accounts	0	0	0
Write-offs	0	0	0
Balance at End of Period	$ 32,400	$ 0	$ 0